Sort
82,697 grants matching “vaccine development”
Translational Research to Prevent and Control Global Infectious Diseases (Translational Global Infectious Diseases Research Center, TGIR).
$2,244,419Beth Diane Kirkpatrick · University Of Vermont & St Agric College · P20 · FY2019 · GM
Influenza responses and repertoire in vaccination, infection and tonsil organoids.
$2,244,245Mark M Davis · Stanford University · U19 · FY2022 · AI
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
$2,243,861Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2024 · AG
Manufacture of a Vaccine Targeting Frame-Shift Mutations Characteristic of Tumors with Microsatellite Instability
$2,243,667Beth Tebeau · Advanced Bioscience Laboratories, Inc. · N01 · FY2020 · CA
Development of vaccines to bacterial diseases found especially in children
$2,243,180John Robbins · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD
EMORY/ATLANTA CENTER FOR AIDS RESEARCH(CFAR)
$2,241,754James W. Curran · Emory University · P30 · FY2006 · AI
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
$2,241,256S. Mark Tompkins · University Of Georgia · N01 · FY2025 · AI
Innovative Strategies to Combat Antibiotic-resistant Infections
$2,238,702Scott J Hultgren · Washington University · U19 · FY2024 · AI
IND-enabling Preclinical Studies on Anti-Tau AD Vaccine for Phase 1 Trial
$2,237,972Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2022 · AG
Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit
$2,237,757Scott M Hammer · Columbia University Health Sciences · UM1 · FY2016 · AI
Adoptive Cell Transfer Immunotherapy of Cancer
$2,237,547Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Flavivirus Infections: Pathogenesis and Prevention
$2,236,376Alan L Rothman · Univ Of Massachusetts Med Sch Worcester · P01 · FY2010 · AI
United States Military HIV Research Program (MHRP) Clinical Trials Unit
$2,234,831Robert A. Gramzinski · Walter Reed Army Institute Of Research · UM1 · FY2019 · AI
Simian Vaccine Evaluation Units
$2,234,688Mark Lewis · Bioqual, Inc. · N01 · FY2010 · AI
Simian Vaccine Evaluation Unit: Operation of a Nonhuman Primate Breeding Colony
$2,234,610Francois Villinger · University Of Louisiana At Lafayette · N01 · FY2025 · AI
Development/production of seasonal and pandemic influenza DNA vaccines
$2,233,172Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2009 · AI
Production of Alternate Adenovector Filovirus Vaccines
$2,233,172Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2009 · AI
SPORE in Breast Cancer
$2,233,067Sara Sukumar · Johns Hopkins University · P50 · FY2009 · CA
SPORE in Breast Cancer
$2,233,067Sara Sukumar · Johns Hopkins University · P50 · FY2008 · CA
SPORE in Breast Cancer
$2,233,067Nancy E Davidson · Johns Hopkins University · P50 · FY2007 · CA
SPORE in Breast Cancer
$2,233,067Sara Sukumar · Johns Hopkins University · P50 · FY2010 · CA
Ecopathogenomics of sexually transmitted infections (EPSTI)
$2,230,041Patrik M Bavoil · University Of Maryland Baltimore · U19 · FY2016 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
$2,229,796Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2020 · AI
Vaccine Induced Immunity in the Young and Aged
$2,229,650Rafi Ahmed · Emory University · U19 · FY2022 · AI
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
$2,229,428Lisa Rider · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES